1. HBW Insight

Open: US FDA’s Docket For NAC Comments, And CRN On Its Options To Contest Enforcement

 
• By Malcolm Spicer

Docket remained closed for a few days after FDA asked for additional comments on whether to conduct NAC rulemaking. FDA, says CRN, turned DSHEA on its head in 2020 when it said NAC was approved as a drug and couldn’t be used as a dietary ingredient.

aged and worn vintage photo of open sign
• Source: Shutterstock

The docket for public comments on whether the US Food and Drug Administration should conduct a rulemaking to allow using N-acetyl-L-cysteine in dietary supplements is open, and so is the Council for Responsible Nutrition to all its options to contest the agency’s actions on the ingredient.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation